IRF3 and dermatomyositis: Οur lab has shown that mDCs are a major driver of DM through their increased cell count in DM skin, high production of IFNβ and IL-31 (a driver of itch in DM), and activation of IRF3 (an upstream pathway marker involved in the induction of type-1 IFNs).